Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2025-03-21 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
5.1 UCB_IAR_2024_ENG.pdf
Annual Report Classification · 1% confidence The document is titled 'Integrated Annual Report 2024' and explicitly states it contains the management report, corporate governance statement, sustainability statement, and financials. It covers the company's performance for the full fiscal year 2024. This aligns with the definition of an Annual Report (10-K). FY 2024
2025-03-21 English
8.1. Remuneration_Policy_2025_EN.pdf
Remuneration Information Classification · 1% confidence The document is titled 'UCB Remuneration Policy 2025'. It details the company's reward philosophy, compensation structure for the Executive Committee and Non-Executive Directors, and specific changes to remuneration elements (e.g., attendance fees, equity guidelines, annual bonus targets). This content is specifically designed to inform shareholders and stakeholders about executive compensation practices, which falls under the category of Remuneration Information (DEF 14A).
2025-03-21 English
7.2. FR_Remuneration Report 2024 FR.pdf
Remuneration Information Classification · 1% confidence The document is a detailed 'Rapport de rémunération' (Remuneration Report) for UCB, covering 2024 performance metrics, executive compensation structures (fixed, variable, LTI), and proposed policy changes for 2025. It explicitly discusses the alignment of compensation with shareholder interests and regulatory requirements for executive pay. This content aligns perfectly with the 'Remuneration Information' category, which is designated by the code 'DEF 14A' in the provided schema.
2025-03-21 French
3.2 UCB SA_Management Report Statutory Accounts 2024 FR Final.pdf
Annual Report Classification · 1% confidence The document is titled 'Rapport annuel du Conseil d'Administration' (Annual Report of the Board of Directors) for UCB SA for the fiscal year ending December 31, 2024. It contains statutory financial data, including balance sheet summaries, profit and loss details, dividend proposals, and management commentary on financial events. While it references an 'Integrated Annual Report' for consolidated group data, this specific document serves as the standalone statutory annual report for the parent company (UCB SA) as required by Belgian law. It is not an announcement (RPA) but the report itself, containing substantive financial statements and management analysis. FY 2024
2025-03-21 French
2.2 Proxy General Meeting 24 April 2025 - FR - Final.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Procuration pour l'Assemblée Générale' (Proxy Form for the General Meeting) for UCB SA. It provides shareholders with the necessary information and a template to appoint a proxy and cast votes on specific agenda items (such as approval of accounts, remuneration policy, and board appointments) for the upcoming Annual General Meeting on April 24, 2025. This document is a standard proxy solicitation material sent to shareholders to facilitate their participation in the meeting.
2025-03-21 French
6.2. Statutory Account NBB_UCB SA_31.12.2024 _FR Final.pdf
Audit Report / Information Classification · 1% confidence The document is a formal Belgian 'Comptes Annuels' (Annual Accounts) filing, which includes identification data, a list of directors, and a balance sheet (Bilan). This is a standard statutory financial filing required by the Belgian Code of Companies and Associations. While it contains financial data, it is the official annual financial statement filing rather than a narrative Annual Report (10-K) or a quarterly report. Given the structure and regulatory nature of this filing, it is classified as an Audit Report/Information (AR) as it represents the formal audited financial statements. FY 2024
2025-03-21 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.